Biochemical and Biophysical Research Communications
Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 3-O-β-d-glucopyanosylspinasterol via blocking NF-κB and STAT1 signaling pathways in TNF-α and IFN-γ-induced HaCaT keratinocytes
Highlights
► Spinasterol-Glc suppressed expression of CCL17 induced by TNF-α and IFN-γ in HaCaT cells. ► Activation of c-Raf-1, p38 MAPK, JAK2, and IKK was attenuated by spinasterol-Glc in HaCaT cells. ► Spinasterol-Glc inhibits TNF-α/IFN-γ-induced production of CCL17 via blocking NF-κB and STAT1 activation.
Introduction
Keratinocytes play an important function in the pathogenesis of inflammatory skin diseases such as atopic dermatitis (AD). AD is commonly characterized by infiltration of Th2-type lymphocytes into skin lesions and is known to be associated with high levels of chemokines like TARC/CCL17 [1], [2], [3], [4]. TARC/CCL17 belongs to a CC chemokine family, attracts CCR4 + Th2 type T cells, and is therefore thought to be related to the development of Th2-mediated inflammatory diseases. It is constitutively expressed in the thymus and keratinocytes, and also produced in other various cell types including endothelial cells and dendritic cells [5], [6], [7]. Exposure of keratinocytes to TNF-α and/or IFN-γ induced an abnormal expression of cytokines and chemokines including TARC/CCL17, leading to infiltration of T cells or leukocytes into the site of inflammatory lesion in the skin [1]. It has been reported that TNF-α and IFN-γ stimulate production of TARC/CCL17 synergistically not only in primary human keratinocyte but also in human keratinocyte cell line, HaCaT cells [7], [8]. Thus, the downregulation of TARC/CCL17 production in keratinocytes can be effective for treatment of skin diseases.
A variety of herbs and plants have been traditionally used in oriental folk medicine for the treatment of inflammatory diseases. Plant extracts and natural compounds are widely recognized as potential sources of therapeutic agents for prevention and treatment of diseases including inflammatory skin diseases [9], [10], [11]. It has been reported that the extracts from Stewartia koreana leaves induced angiogenesis, extracellular matrix remodeling in a mouse model, and stimulate wound healing on punched skin of the back of mice [12]. A phytosterol derivative, 3-O-β-d-glucopyanosylspinasterol (spinasterol-Glc), was isolated from the extracts of S. koreana and was identified as an active compound with strong anti-inflammatory activities [13], [14], [15].
The mechanisms of action by which spinasterol-Glc exhibits anti-inflammatory activities in different cell types still remain unclear. In the present study, we investigated the effects of spinastol-Glc on production of TARC/CCL17 induced by TNF-α/IFN-γ and the mechanism of its action by which it inhibits the TNF-α/IFN-γ-induced production of TARC/CCL17 in HaCaT keratinocyte cells. We showed that spinasterol-Glc suppressed expression of TARC/CCL17 mRNA and protein induced by TNF-α/IFN-γ. We found that spinasterol-Glc inhibited phosphorylation of Raf1, p38 MAP kinase, JAK2 and STAT1. Furthermore, we demonstrated that spinasterol-Glc inhibited TNF-α/IFN-γ-induced activation of NF-κB and STAT1 and the binding of the factors to the DNA elements contained in TARC/CCL17 promoter.
Section snippets
Cell culture and reagents
The human keratinocyte HaCaT cells were grown in Dulbecco’s modified Eagle’s medium supplemented with 10% FBS and antibiotics (100 unit/ml penicillin, 100 μg/ml streptomycin) at 37 °C in a humidified incubator containing 5% CO2 and 95% air. Dulbecco’s modified Eagle’s medium (DMEM), FBS, antibiotics, and trypsin–EDTA were obtained from Invitrogen (Carlsbad, CA). Signal inhibitors, BAY11-7082, c-Raf Inhibitor(1-(3-(1,4-dihydroimidazo[4,5-c]pyrazol-5-yl)-4-methylphenyl)-3-(3-(4-methyl-1H
Spinasterol-Glc inhibited TNF-α/IFN-γ-induced expression of TARC/CCL17 in HaCaT keratinocyte cells
To investigate the effects of spinasterol-Glc on TARC/CCL17 production in TNF-α/IFN-γ-stimulated keratinocyte cells, HaCaT cells were pretreated with various concentrations of spinasterol-Glc for 1 h and then stimulated with TNF-α/IFN-γ for 18 h. TARC/CCL17 production increased markedly up to 186 pg/ml in response to stimulation with TNF-α/IFN-γ, comparing to that of basal level (18 pg/ml). Spinasterol-Glc profoundly inhibited the TNF-α/IFN-γ-induced production of TARC/CCL17 in a dose-dependent
Discussion
We have previously demonstrated that spinasterol-Glc suppressed LPS-induced expression of iNOS and cytokine genes such as TNF-α, IL-1β and IL-6 in RAW264.7 murine macrophage cells via inhibiting nuclear translocation and binding of NF-κB to the DNA elements of its target genes [15]. Concomitant with the decreased NF-κB binding, spinasterol-Glc inhibited the activation of ERK1/2, JNK, and p38 MAP kinases, which contribute to the regulation of LPS-stimulated cytokine production in macrophage
Acknowledgement
This research was supported by the grant from the Next Generation BioGreen 21 program [PJ007985], Rural Development Administration, Republic of Korea.
References (25)
- et al.
Cytokines and chemokines orchestrate atopic skin inflammation
J. Aller. Clin. Immunol.
(2006) - et al.
Thymus and activation-regulated chemokine in atopic dermatitis: serum thymus and activation-regulated chemokine level is closely related with disease activity
Aller. Clin. Immunol.
(2001) - et al.
Both Th2 and Th1 chemokines (TARC/CCL17, MDC/CCL22, and Mig/CXCL9) are elevated in sera from patients with atopic dermatitis
J. Dermatol. Sci.
(2004) - et al.
A Th2chemokine, TARC, produced by keratinocytes may recruit CLA+CCR4+ lymphocytes into lesional atopic dermatitis skin
J. Invest. Dermatol.
(2000) - et al.
Molecular cloning of a novel T cell-directed CC chemokine expressed in thymus by signal sequence trap using Epstein-Barr virus vector
J. Biol. Chem.
(1996) - et al.
Thymus and activation regulated chemokine (TARC)/CCL17 and skin diseases
J. Dermatol. Sci.
(2006) - et al.
Mechanism of thymus- and activation-regulated chemokine (TARC)/CCL17 production and its modulation by roxithromycin
J. Invest. Dermatol.
(2005) - et al.
Suppression of thymus- and activation-regulated chemokine (TARC/CCL17) production by 1,2,3,4,6-penta-O-galloyl-beta-d-glucose via blockade of NF-kappaB and STAT1 activation in the HaCaT cells
Biochem. Biophys. Res. Commun.
(2009) - et al.
Psidium guajava extract inhibits thymus and activation-regulated chemokine (TARC/CCL17) production in human keratinocytes by inducing heme oxygenase-1 and blocking NF-κB and STAT1 activation
Environ. Toxicol. Pharmacol.
(2011) - et al.
Casuarinin suppresses TARC/CCL17 and MDC/CCL22 production via blockade of NF-κB and STAT1 activation in HaCaT cells
Biochem. Biophys. Res. Commun.
(2012)
Inhibitory effects of S. koreana on osteoclast differentiation and bone resorption
Int. Immunopharmacol.
Inhibitory effects of a spinasterol glycoside on lipopolysaccharide-induced production of nitric oxide and proinflammatory cytokines via down-regulating MAP kinase pathways and NF-κB activation in RAW264.7 macrophage cells
Int. Immunopharmacol.
Cited by (42)
Eckol from Ecklonia cava ameliorates TNF-α/IFN-γ-induced inflammatory responses via regulating MAPKs and NF-κB signaling pathway in HaCaT cells
2020, International ImmunopharmacologyCitation Excerpt :Keratinocytes, a major group of epidermal cells, play a key role in pathogenesis of inflammatory skin lesion [21,22]. Previous studies have shown that the stimulation of keratinocytes by TNF-α and IFN-γ can trigger the expression of inflammatory mediators such as cytokines, chemokines and adhesion molecules, leading to skin inflammation [21–24]. In this study, we evaluated the effect of eckol on pro-inflammatory cytokines and chemokines caused by TNF-α/IFN-γ in HaCaT cells.
In vitro evidences of the traditional use of Rhus coriaria L. fruits against skin inflammatory conditions
2019, Journal of EthnopharmacologyCitation Excerpt :Consequently, the downregulation of keratinocytes inflammatory chemokine production and the inhibition of their interaction with immune cells may be an effective target in the treatment of inflammatory skin diseases (Kwon et al., 2012; Yang et al., 2015). Anti-TNF-α antibodies have been used efficiently for the management of immune-mediated inflammatory diseases including rheumatoid arthritis, Crohn's disease, ulcerative colitis and psoriasis (Jung et al., 2012 #441). Although blockage of TNF-α, by anti-TNF-α agents, such as Infliximab, Etanercept and Adalimumab, which bind TNF-α with high affinity, has been shown to successfully treat psoriasis, they can cause serious side effects (Chan et al., 2008; Ganguly, 2009; Makol and Grover, 2008; Silva et al., 2010).
Anti-inflammatory effects of Perillae Herba ethanolic extract against TNF-α/IFN-γ-stimulated human keratinocyte HaCaT cells
2018, Journal of EthnopharmacologyEffect of Stewartia koreana Boiling Extract (SKBE) on Osteoarthritis and Purification of Spinasterol From SKBE
2023, Journal of the Korean Chemical Society